Show simple item record

dc.contributor.authorDenkinger, C M
dc.contributor.authorDolinger, D
dc.contributor.authorSchito, M
dc.contributor.authorWells, W
dc.contributor.authorCobelens, F
dc.contributor.authorPai, M
dc.contributor.authorZignol, M
dc.contributor.authorCirillo, D M
dc.contributor.authorAlland, D
dc.contributor.authorCasenghi, M
dc.contributor.authorGallarda, J
dc.contributor.authorBoehme, C C
dc.contributor.authorPerkins, M D
dc.date.accessioned2015-04-23T22:56:58Z
dc.date.available2015-04-23T22:56:58Z
dc.date.issued2015-04-01
dc.identifier.citationTarget Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centers. 2015, 211 (suppl 2):S39-S49 J. Infect. Dis.en_GB
dc.identifier.issn1537-6613
dc.identifier.pmid25765105
dc.identifier.doi10.1093/infdis/jiu682
dc.identifier.urihttp://hdl.handle.net/10144/550558
dc.description.abstractCurrent phenotypic testing for drug resistance in patients with tuberculosis is inadequate primarily with respect to turnaround time. Molecular tests hold the promise of an improved time to diagnosis.
dc.languageENG
dc.language.isoenen
dc.publisherOxford University Pressen_GB
dc.rightsPublished by Infectious Diseases Society of America Archived on this site with permission and copyright 2015 by the Infectious Diseases Society of America, [url] and Oxford University Press with Open Access optionen_GB
dc.titleTarget Product Profile of a Molecular Drug-Susceptibility Test for Use in Microscopy Centersen
dc.identifier.journalJournal of Infectious Diseasesen_GB
refterms.dateFOA2019-03-04T12:23:24Z
html.description.abstractCurrent phenotypic testing for drug resistance in patients with tuberculosis is inadequate primarily with respect to turnaround time. Molecular tests hold the promise of an improved time to diagnosis.


Files in this item

Thumbnail
Name:
Denkinger et al - 2015 - Target ...
Size:
374.1Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record